Роль мутаций в гене NF1 в спорадическом канцерогенезе for targeted
therapy of both neurofibromatosis type 1 and sporadic neoplasms with mutations of this gene
KHABIBOV, M.,
GARIFULLIN, A.,
KHAMITOV, F.,
KHALIKOVA, L.,
BOUMBER, Y.,
KHADDOUR, K.,
FERNANDEZ, M.,
KUZNETSOVA, N.,
KIT, O.,
KHARIN, L. (2022) in the pathogenesis of GBM, as well as
therapies that target these pathways. Glioblastoma remains a diffi‑
cult
Asadullina, D.D.,
Gilyazova, I.R.,
Ivanova, E.A.,
Izmailova, S.M.,
Gilyazova, G.R.,
Pavlov, V.N.,
Khusnutdinova, E.K. (2024) . Disruption of miRNA regulation may affect ccRCC immunogenicity and response to ICI
therapy, making them